Joost Boeckmans

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Cross Sectional

Cardiovascular Risk Factors

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Archives of toxicology

Cell biology and toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Joost Boeckmans, Jörn Markus Schattenberg
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: insights from the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Joost Boeckmans, Jörn Markus Schattenberg
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Elias Iturrospe, Rani Robeyns, Katyeny Manuela da Silva, Maria van de Lavoir, Joost Boeckmans, Tamara Vanhaecke, Alexander L N van Nuijs, Adrian Covaci
Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC-MS-based untargeted metabolomics. Archives of toxicology (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim M Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis. A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, Jörn Markus Schattenberg
Liver stiffness as a cornerstone in heart disease risk assessment. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M Rodrigues, Tamara Vanhaecke
Infections at the nexus of metabolic-associated fatty liver disease. Archives of toxicology 95 (7) (2021)
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Brent Cami, Veerle De Boe, Anja Heymans, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Marcelino Rodrigues
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists. Cell biology and toxicology 37 (2) (2020)